Biomarkers of Tuberculosis Severity and Treatment Effect: A Directed Screen of 70 Host Markers in a Randomized Clinical Trial

More efficacious treatment regimens are needed for tuberculosis, however, drug development is impeded by a lack of reliable biomarkers of disease severity and of treatment effect. We conducted a directed screen of host biomarkers in participants enrolled in a tuberculosis clinical trial to address t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sigal, G.B., Segal, M.R., Mathew, A., Jarlsberg, L., Wang, M., Barbero, S., Small, N., Haynesworth, K., Davis, J.L., Weiner, M., Whitworth, W.C., Jacobs, J., Schorey, J., Lewinsohn, D.M., Nahid, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704068/
https://www.ncbi.nlm.nih.gov/pubmed/29100778
http://dx.doi.org/10.1016/j.ebiom.2017.10.018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704068/
https://www.ncbi.nlm.nih.gov/pubmed/29100778
http://dx.doi.org/10.1016/j.ebiom.2017.10.018

Ejemplares similares